A Study to Investigate Changes in Symptoms in Adult Participants With Chronic Rhinosinusitis With Nasal Polyposis Initiating Treatment With Tezepelumab
Clinical trial NCT06706817 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06706817
- Sponsor
- AstraZeneca
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-03
- Primary completion
- 2027-01-13
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.